New emerging targets in cancer immunotherapy beyond CTLA-4, PD-1 and PD-L1: Introducing an "ESMO Open - Cancer Horizons" Series

ESMO Open. 2019 Jun 12;4(Suppl 3):e000501. doi: 10.1136/esmoopen-2019-000501. eCollection 2019.

¹ Department of Medical Oncology, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy. Electronic address: matteo.lambertini@unige.it.
² Clinical Divison of Oncology, Department of Medicine I, General Hospital - Medical University Vienna, Vienna, Austria.
³ Vienna Cancer Center, City of Vienna - Medical University Vienna, Vienna, Austria.

No abstract available

Keywords: immunotherapy.

Publication types